Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Francine Kay Welty, PH.D., M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Effect of Soy Phytoestrogens and Low-Dose Estrogens on Lipid Levels, Brachial Artery Function, and Biochemical Markers of Bone Turnover in Postmenopausal Women
Full Time/Year Long, 07/05/00 - 06/29/01
Soy in Postmenopausal Women
Part Time/Continuation, 10/20/00 - 12/31/00
Phytoestrogens and Low-Dose Estrogen in Postmenopausal Women
Part Time, 03/20/00 - 06/16/00

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DE018184 (WELTY, FRANCINE K) Aug 10, 2007 - Jul 31, 2014
    NIH/NIDCR
    Periodontal Disease and Coronary Artery Remodeling in CHD and Metabolic Syndrome
    Role: Principal Investigator
  2. P50HL083813 (WELTY, FRANCINE K) May 1, 2006 - Mar 31, 2015
    NIH/NHLBI
    Metabolic Syndrome, Inflammation and Vascular Remodeling
    Role: Principal Investigator
  3. K07DK002974 (WELTY, FRANCINE K) Sep 1, 2000 - Aug 31, 2007
    NIH/NIDDK
    TEACHING NUTRITION TO PREVENT CARDIOVASCULAR DISEASES
    Role: Principal Investigator
  4. R01HL056895 (WELTY, FRANCINE K) Aug 15, 1997 - Jun 30, 2009
    NIH/NHLBI
    ApoB and ApoA-I Kinetics in the ApoB-67 Mutation
    Role: Principal Investigator
  5. R29HL056895 (WELTY, FRANCINE K) Aug 15, 1997 - Jun 30, 2001
    NIH/NHLBI
    MECHANISMS OF LOW LEVELS OF APOLIPOPROTEIN B
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Saleh M, Alfaddagh A, Elajami TK, Ashfaque H, Haj-Ibrahim H, Welty FK. Diastolic blood pressure predicts coronary plaque volume in patients with coronary artery disease. Atherosclerosis. 2018 Jul 29; 277:34-41. PMID: 30170222.
    View in: PubMed
  2. Alfaddagh A, Elajami TK, Saleh M, Elajami M, Bistrian BR, Welty FK. The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial. J Clin Lipidol. 2018 Jul - Aug; 12(4):937-947.e2. PMID: 29752179.
    View in: PubMed
  3. Alfaddagh A, Elajami TK, Ashfaque H, Saleh M, Bistrian BR, Welty FK. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial. J Am Heart Assoc. 2017 Dec 15; 6(12). PMID: 29246960.
    View in: PubMed
  4. Elajami TK, Alfaddagh A, Lakshminarayan D, Soliman M, Chandnani M, Welty FK. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. J Am Heart Assoc. 2017 Jul 14; 6(7). PMID: 28710178.
    View in: PubMed
  5. Hachem A, Hariri E, Saoud P, Lteif C, Lteif L, Welty F. The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review. Curr Cardiol Rev. 2017; 13(4):274-282. PMID: 28782494.
    View in: PubMed
  6. Elajami TK, Giuseffi J, Avila MD, Hovnanians N, Mukamal KJ, Parikh N, Welty FK. Parity, coronary heart disease and mortality in the old order Amish. Atherosclerosis. 2016 11; 254:14-19. PMID: 27680773.
    View in: PubMed
  7. Lakshminarayan D, Elajami TK, Devabhaktuni S, Welty FK. Ischemic stroke in a young adult with extremely elevated lipoprotein(a): A case report and review of literature. J Clin Lipidol. 2016 Sep-Oct; 10(5):1266-71. PMID: 27678446.
    View in: PubMed
  8. Hauser TH, Salastekar N, Schaefer EJ, Desai T, Goldfine HL, Fowler KM, Weber GM, Welty F, Clouse M, Shoelson SE, Goldfine AB. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins. JAMA Cardiol. 2016 07 01; 1(4):413-23. PMID: 27438317.
    View in: PubMed
  9. Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J. 2016 08; 30(8):2792-801. PMID: 27121596; PMCID: PMC4970606 [Available on 08/01/17].
  10. Hartman ML, Goodson JM, Shi P, Vargas J, Yaskell T, Stephens D, Cugini M, Hasturk H, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Unhealthy Phenotype as Indicated by Salivary Biomarkers: Glucose, Insulin, VEGF-A, and IL-12p70 in Obese Kuwaiti Adolescents. J Obes. 2016; 2016:6860240. PMID: 27069678; PMCID: PMC4812454.
  11. Regensteiner JG, Golden S, Huebschmann AG, Barrett-Connor E, Chang AY, Chyun D, Fox CS, Kim C, Mehta N, Reckelhoff JF, Reusch JE, Rexrode KM, Sumner AE, Welty FK, Wenger NK, Anton B. Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation. 2015 Dec 22; 132(25):2424-47. PMID: 26644329.
    View in: PubMed
  12. Welty FK, Lewis SJ, Friday KE, Cain VA, Anzalone DA. A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study. J Womens Health (Larchmt). 2016 Jan; 25(1):50-6. PMID: 26539650; PMCID: PMC4741209.
  13. Shi P, Goodson JM, Hartman ML, Hasturk H, Yaskell T, Vargas J, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers. PLoS One. 2015; 10(9):e0138979. PMID: 26418011; PMCID: PMC4587796.
  14. Hegele RA, Gidding SS, Ginsberg HN, McPherson R, Raal FJ, Rader DJ, Robinson JG, Welty FK. Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. Arterioscler Thromb Vasc Biol. 2015 Nov; 35(11):2269-80. PMID: 26376908; PMCID: PMC4758700 [Available on 11/01/16].
  15. Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016 Jan; 167(1):257-80. PMID: 26207884.
    View in: PubMed
  16. Singh V, Luthra S, Elajami TK, Welty FK. Resolution of NASH with weight loss documented by hepatic MRI. BMJ Case Rep. 2015 Jan 06; 2015. PMID: 25564638.
    View in: PubMed
  17. Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children. Diabetes Metab Syndr Obes. 2015; 8:9-15. PMID: 25565874; PMCID: PMC4274134.
  18. Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 2015 Feb; 64(2):236-43. PMID: 25441251.
    View in: PubMed
  19. Goodson JM, Kantarci A, Hartman ML, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Metabolic disease risk in children by salivary biomarker analysis. PLoS One. 2014; 9(6):e98799. PMID: 24915044; PMCID: PMC4051609.
  20. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol. 2014 Jun; 25(3):161-8. PMID: 24751931; PMCID: PMC4465983.
  21. Jon AF, Cheema AR, Khan AN, Raptopoulos V, Hauser T, Nasser I, Welty FK, Karellas A, Clouse ME. Assessment of liver fat in an obese patient population using noncontrast CT fat percent index. Clin Imaging. 2014 May-Jun; 38(3):259-64. PMID: 24559751; PMCID: PMC3999172.
  22. Welty FK. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep. 2013 Sep; 15(9):400. PMID: 23881582; PMCID: PMC4465984.
  23. Khosa F, Khan AN, Nasir K, Bedayat A, Malik Z, Jon AF, Cheema AR, Clouse ME, Welty FK. Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA. Atherosclerosis. 2013 Feb; 226(2):428-32. PMID: 23287639; PMCID: PMC4758671.
  24. Ooi EM, Lichtenstein AH, Millar JS, Diffenderfer MR, Lamon-Fava S, Rasmussen H, Welty FK, Barrett PH, Schaefer EJ. Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. J Lipid Res. 2012 Sep; 53(9):1958-67. PMID: 22773687; PMCID: PMC3413235.
  25. Ensrud K, LaCroix A, Thompson JR, Thompson DD, Eastell R, Reid DM, Vukicevic S, Cauley J, Barrett-Connor E, Armstrong R, Welty F, Cummings S. Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial. Circulation. 2010 Oct 26; 122(17):1716-24. PMID: 20937977.
    View in: PubMed
  26. Berger JE, Ahmann AJ, Balfour DC, Owens GS, Beltran R, Bush MA, Culpepper L, Owens GS, Ringel M, Welty FK. Treating to target: implementing an effective diabetes care paradigm for managed care. Am J Manag Care. 2010 Mar; 16 Suppl Treating:S4-35. PMID: 20297878.
    View in: PubMed
  27. Ruan Y, Bridges JS, Kumar K, Raphael JA, Acharjee S, Welty FK. Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome. Clin Rheumatol. 2008 Dec; 27(12):1577-9. PMID: 18716731.
    View in: PubMed
  28. Clouse ME, Sabir A, Yam CS, Yoshimura N, Lin S, Welty F, Martinez-Clark P, Raptopoulos V. Measuring noncalcified coronary atherosclerotic plaque using voxel analysis with MDCT angiography: a pilot clinical study. AJR Am J Roentgenol. 2008 Jun; 190(6):1553-60. PMID: 18492906.
    View in: PubMed
  29. Nasca MM, Zhou JR, Welty FK. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol. 2008 Jul 01; 102(1):84-6. PMID: 18572041; PMCID: PMC3229929.
  30. Acharjee S, Welty FK. Atorvastatin and cardiovascular risk in the elderly--patient considerations. Clin Interv Aging. 2008; 3(2):299-314. PMID: 18686752; PMCID: PMC2546474.
  31. Wenger NK, Lewis SJ, Welty FK, Herrington DM, Bittner V. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Heart. 2008 Apr; 94(4):434-9. PMID: 18070940.
    View in: PubMed
  32. Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Cohn JS, Wilson A, Wolfe ML, Nartsupha C, Schaefer PM, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. J Lipid Res. 2008 Mar; 49(3):543-9. PMID: 18033754.
    View in: PubMed
  33. Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med. 2007 Jul 03; 147(1):1-9. PMID: 17606955.
    View in: PubMed
  34. Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ, Marsh JB. Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women. Metabolism. 2007 Jul; 56(7):910-4. PMID: 17570251; PMCID: PMC2727057.
  35. Welty FK, Lee KS, Lew NS, Zhou JR. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med. 2007 May 28; 167(10):1060-7. PMID: 17533209.
    View in: PubMed
  36. Welty FK, Nasca MM, Lew NS, Gregoire S, Ruan Y. Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office. Am J Cardiol. 2007 Jul 01; 100(1):73-5. PMID: 17599444; PMCID: PMC2726994.
  37. Welty FK, Lee KS, Lew NS, Nasca M, Zhou JR. The association between soy nut consumption and decreased menopausal symptoms. J Womens Health (Larchmt). 2007 Apr; 16(3):361-9. PMID: 17439381; PMCID: PMC3229924.
  38. Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Arterioscler Thromb Vasc Biol. 2006 Jun; 26(6):1350-6. PMID: 16574893.
    View in: PubMed
  39. Sommer U, Herscovitz H, Welty FK, Costello CE. LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J Lipid Res. 2006 Apr; 47(4):804-14. PMID: 16443931.
    View in: PubMed
  40. Lamon-Fava S, Postfai B, Diffenderfer M, DeLuca C, O'Connor J, Welty FK, Dolnikowski GG, Barrett PH, Schaefer EJ. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):385-91. PMID: 16339502; PMCID: PMC3229925.
  41. Delichatsios HK, Welty FK. Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure. Curr Atheroscler Rep. 2005 Nov; 7(6):446-54. PMID: 16256002.
    View in: PubMed
  42. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation. 2005 Jul 26; 112(4):563-71. PMID: 16009795.
    View in: PubMed
  43. Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arterioscler Thromb Vasc Biol. 2005 Aug; 25(8):1691-6. PMID: 15933247.
    View in: PubMed
  44. Dolnikowski GG, Marsh JB, Das SK, Welty FK. Stable isotopes in obesity research. Mass Spectrom Rev. 2005 May-Jun; 24(3):311-27. PMID: 15389849.
    View in: PubMed
  45. Brousseau ME, Diffenderfer MR, Millar JS, Nartsupha C, Asztalos BF, Welty FK, Wolfe ML, Rudling M, Björkhem I, Angelin B, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ. Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1057-64. PMID: 15761191; PMCID: PMC3229922.
  46. Jenner JL, Seman LJ, Millar JS, Lamon-Fava S, Welty FK, Dolnikowski GG, Marcovina SM, Lichtenstein AH, Barrett PH, deLuca C, Schaefer EJ. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism. 2005 Mar; 54(3):361-9. PMID: 15736114.
    View in: PubMed
  47. Batista MC, Welty FK, Diffenderfer MR, Sarnak MJ, Schaefer EJ, Lamon-Fava S, Asztalos BF, Dolnikowski GG, Brousseau ME, Marsh JB. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism. 2004 Oct; 53(10):1255-61. PMID: 15375779.
    View in: PubMed
  48. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Arterioscler Thromb Vasc Biol. 2004 Sep; 24(9):1703-7. PMID: 15242863.
    View in: PubMed
  49. Welty FK. Preventing clinically evident coronary heart disease in the postmenopausal woman. Menopause. 2004 Jul-Aug; 11(4):484-94. PMID: 15243287.
    View in: PubMed
  50. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, Eckel RH, Schaefer EJ, Lichtenstein AH. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004 Jun; 24(6):1092-7. PMID: 15087307.
    View in: PubMed
  51. Tilly-Kiesi M, Schaefer EJ, Knudsen P, Welty FK, Dolnikowski GG, Taskinen MR, Lichtenstein AH. Lipoprotein metabolism in subjects with hepatic lipase deficiency. Metabolism. 2004 Apr; 53(4):520-5. PMID: 15045702.
    View in: PubMed
  52. Welty FK. Alternative hormone replacement regimens: is there a need for further clinical trials? Curr Opin Lipidol. 2003 Dec; 14(6):585-91. PMID: 14624135.
    View in: PubMed
  53. Welty FK. Nutrition and Women's Health Symposium. Introduction. J Womens Health (Larchmt). 2003 Mar; 12(2):105-8. PMID: 12737708.
    View in: PubMed
  54. Marsh JB, Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ. Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. Atherosclerosis. 2002 Jun; 162(2):227-44. PMID: 11996942.
    View in: PubMed
  55. Welty FK, Stuart E, O'Meara M, Huddleston J. Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol. Am J Cardiol. 2002 May 15; 89(10):1201-4. PMID: 12008176.
    View in: PubMed
  56. Schaefer EJ, Brousseau ME, Diffenderfer MR, Cohn JS, Welty FK, O'Connor J, Dolnikowski GG, Wang J, Hegele RA, Jones PJ. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis. 2001 Nov; 159(1):231-6. PMID: 11689226.
    View in: PubMed
  57. Welty FK, Guida KA, Andersen JJ. Donor splice-site mutation (210+1G_C) in the ApoB gene causes a very low level of ApoB-100 and LDL cholesterol. Arterioscler Thromb Vasc Biol. 2001 Nov; 21(11):1864-5. PMID: 11701479.
    View in: PubMed
  58. Welty FK. Women and cardiovascular risk. Am J Cardiol. 2001 Oct 11; 88(7B):48J-52J. PMID: 11595200.
    View in: PubMed
  59. Welty FK, Lewis SM, Kowalker W, Shubrooks SJ. Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal coronary angioplasty in women compared with men. Am J Cardiol. 2001 Sep 01; 88(5):473-7. PMID: 11524052.
    View in: PubMed
  60. Sun Z, Welty FK, Dolnikowski GG, Lichtenstein AH, Schaefer EJ. Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma. Am J Clin Nutr. 2001 Sep; 74(3):308-14. PMID: 11522553.
    View in: PubMed
  61. Sun Z, Lichtenstein AH, Dolnikowski GG, Welty FK, Schaefer EJ. Human apolipoprotein A-IV metabolism within triglyceride-rich lipoproteins and plasma. Atherosclerosis. 2001 Jun; 156(2):363-72. PMID: 11395033.
    View in: PubMed
  62. Raggi P, Callister TQ, Davidson M, Welty FK, Bachmann GA, Laskey R, Pittman D, Kafonek S, Scott R. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial. Am Heart J. 2001 May; 141(5):722-6. PMID: 11320358.
    View in: PubMed
  63. Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med. 2001 Feb 26; 161(4):514-22. PMID: 11252110.
    View in: PubMed
  64. Welty FK, Lichtenstein AH, Barrett PH, Jenner JL, Dolnikowski GG, Schaefer EJ. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Arterioscler Thromb Vasc Biol. 2000 Jul; 20(7):1807-10. PMID: 10894821.
    View in: PubMed
  65. Marsh JB, Welty FK, Schaefer EJ. Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans. Curr Opin Lipidol. 2000 Jun; 11(3):261-6. PMID: 10882341.
    View in: PubMed
  66. Welty FK. Optimal management of non-ST segment elevation myocardial infarction remains unclear. J Am Coll Cardiol. 2000 Mar 15; 35(4):903-6. PMID: 10732886.
    View in: PubMed
  67. Velez-Carrasco W, Lichtenstein AH, Li Z, Dolnikowski GG, Lamon-Fava S, Welty FK, Schaefer EJ. Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3):801-6. PMID: 10712406.
    View in: PubMed
  68. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol. 1999 Dec; 19(12):2966-74. PMID: 10591677.
    View in: PubMed
  69. Vélez-Carrasco W, Lichtenstein AH, Barrett PH, Sun Z, Dolnikowski GG, Welty FK, Schaefer EJ. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J Lipid Res. 1999 Sep; 40(9):1695-700. PMID: 10484617.
    View in: PubMed
  70. Vélez-Carrasco W, Lichtenstein AH, Welty FK, Li Z, Lamon-Fava S, Dolnikowski GG, Schaefer EJ. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion. Arterioscler Thromb Vasc Biol. 1999 Apr; 19(4):918-24. PMID: 10195918.
    View in: PubMed
  71. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PW, Schaefer EJ. Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population. Arterioscler Thromb Vasc Biol. 1998 Nov; 18(11):1745-51. PMID: 9812913.
    View in: PubMed
  72. Gebara OC, Mittleman MA, Walsh BW, Lipinska I, Welty FK, Bellotti G, Muller JE, Sacks FK, Tofler GH. Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart. 1998 Sep; 80(3):235-9. PMID: 9875081; PMCID: PMC1761087.
  73. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. J Lipid Res. 1997 Aug; 38(8):1535-43. PMID: 9300775.
    View in: PubMed
  74. Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Ordovas JM, Schaefer EJ. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Arterioscler Thromb Vasc Biol. 1997 May; 17(5):881-8. PMID: 9157951.
    View in: PubMed
  75. Welty FK, Mittleman MA, Wilson PW, Sutherland PA, Matheney TH, Lipinska I, Muller JE, Levy D, Tofler GH. Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population. Circulation. 1997 Feb 18; 95(4):825-30. PMID: 9054738.
    View in: PubMed
  76. Welty FK, Mittleman MA, Lewis SM, Kowalker WL, Healy RW, Shubrooks SJ, Muller JE. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%. Circulation. 1996 Apr 15; 93(8):1496-501. PMID: 8608616.
    View in: PubMed
  77. Welty FK. Who Should Receive Hormone Replacement Therapy? J Thromb Thrombolysis. 1996; 3(1):13-21. PMID: 10608035.
    View in: PubMed
  78. Welty FK, Seman L, Yen FT. Purification of the apolipoprotein B-67-containing low density lipoprotein particle and its affinity for the low density lipoprotein receptor. J Lipid Res. 1995 Dec; 36(12):2622-9. PMID: 8847488.
    View in: PubMed
  79. Welty FK, Ordovas J, Schaefer EJ, Wilson PW, Young SG. Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels. Circulation. 1995 Oct 15; 92(8):2036-40. PMID: 7554178.
    View in: PubMed
  80. Welty FK, Mittleman MA, Lewis SM, Healy RW, Shubrooks SJ, Muller JE. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol. 1995 Sep 01; 76(7):431-5. PMID: 7653439.
    View in: PubMed
  81. Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995 Apr 01; 91(7):1952-8. PMID: 7895352.
    View in: PubMed
  82. Welty FK, Mittleman MA, Healy RW, Muller JE, Shubrooks SJ. Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia. J Am Coll Cardiol. 1994 Jan; 23(1):35-9. PMID: 8277093.
    View in: PubMed
  83. Welty FK, McLeod GX, Ezratty C, Healy RW, Karchmer AW. Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis. 1992 Nov; 15(5):858-60. PMID: 1445984.
    View in: PubMed
  84. Weinrauch LA, D'Elia JA, Monaco AP, Gleason RE, Welty F, Nishan PC, Nesto RW. Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med. 1992 Jul; 93(1):19-28. PMID: 1626568.
    View in: PubMed
  85. Siu SC, Kowalchuk GJ, Welty FK, Benotti PN, Lewis SM. Intra-aortic balloon counterpulsation support in the high-risk cardiac patient undergoing urgent noncardiac surgery. Chest. 1991 Jun; 99(6):1342-5. PMID: 2036814.
    View in: PubMed
  86. Welty FK, Hubl ST, Pierotti VR, Young SG. A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia. J Clin Invest. 1991 May; 87(5):1748-54. PMID: 2022744; PMCID: PMC295283.
  87. Welty FK, Wood HG. Purification of the "corrinoid" enzyme involved in the synthesis of acetate by Clostridium thermoaceticum. J Biol Chem. 1978 Aug 25; 253(16):5832-8. PMID: 670234.
    View in: PubMed
  88. Welty FK, Smith KL, Schanbacher FL. Lactoferrin concentration during involution of the bovine mammary gland. J Dairy Sci. 1976 Feb; 59(2):224-31. PMID: 1249287.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Welty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (387)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_